These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25538273)

  • 41. High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines.
    Kebe K; Thiam M; Diagne Gueye NR; Diop H; Dia A; Signate Sy H; Charpentier C; Belec L; Mboup S; Toure Kane C
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):242-9. PubMed ID: 22860571
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy.
    Raymond S; Saliou A; Delobel P; Cazabat M; Pasquier C; Jeanne N; Sauné K; Massip P; Marchou B; Izopet J
    J Antimicrob Chemother; 2014 Sep; 69(9):2527-30. PubMed ID: 24840625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma on a 2002-2011 survey.
    Lambert-Niclot S; Tubiana R; Beaudoux C; Lefebvre G; Caby F; Bonmarchand M; Naouri M; Schubert B; Dommergues M; Calvez V; Flandre P; Poirot C; Marcelin AG
    AIDS; 2012 May; 26(8):971-5. PubMed ID: 22382146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01).
    Avettand-Fènoël V; Chaix ML; Blanche S; Burgard M; Floch C; Toure K; Allemon MC; Warszawski J; Rouzioux C;
    J Med Virol; 2009 Feb; 81(2):217-23. PubMed ID: 19107966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time.
    Ghosn J; Pellegrin I; Goujard C; Deveau C; Viard JP; Galimand J; Harzic M; Tamalet C; Meyer L; Rouzioux C; Chaix ML;
    AIDS; 2006 Jan; 20(2):159-70. PubMed ID: 16511408
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA.
    Gianella S; von Wyl V; Fischer M; Niederoest B; Battegay M; Bernasconi E; Cavassini M; Rauch A; Hirschel B; Vernazza P; Weber R; Joos B; Günthard HF;
    Antivir Ther; 2011; 16(4):535-45. PubMed ID: 21685541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial).
    Delaugerre C; Gourlain K; Tubiana R; Carcelain G; Marcelin AG; Chouquet C; Mouroux M; Duvivier C; Autran B; Costagliola D; Katlama C; Calvez V
    Antivir Ther; 2003 Jun; 8(3):233-7. PubMed ID: 12924540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
    Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
    Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
    Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
    J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIV-1 DNA concentrations and evolution among African HIV-1-infected children under antiretroviral treatment (ANRS 1244/1278).
    Boullé C; Rouet F; Fassinou P; Msellati P; Debeaudrap P; Chaix ML; Rouzioux C; Avettand-Fenoel V
    J Antimicrob Chemother; 2014 Nov; 69(11):3047-50. PubMed ID: 25038068
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirs.
    Malatinkova E; De Spiegelaere W; Bonczkowski P; Kiselinova M; Vervisch K; Trypsteen W; Johnson M; Verhofstede C; de Looze D; Murray C; Kinloch-de Loes S; Vandekerckhove L
    Elife; 2015 Oct; 4():e09115. PubMed ID: 26439007
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early Initiation of Antiretroviral Therapy Following In Utero HIV Infection Is Associated With Low Viral Reservoirs but Other Factors Determine Viral Rebound.
    Millar JR; Bengu N; Vieira VA; Adland E; Roider J; Muenchhoff M; Fillis R; Sprenger K; Ntlantsana V; Fatti I; Archary M; Groll A; Ismail N; García-Guerrero MC; Matthews PC; Ndung'u T; Puertas MC; Martinez-Picado J; Goulder P
    J Infect Dis; 2021 Dec; 224(11):1925-1934. PubMed ID: 33963757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monotypic low-level HIV viremias during antiretroviral therapy are associated with disproportionate production of X4 virions and systemic immune activation.
    Bull ME; Mitchell C; Soria J; Styrchak S; Williams-Wietzikoski C; Legard J; McKernan-Mullin J; Kraft K; Onchiri F; Stern J; Holte S; Ryan KJ; Acosta EP; La Rosa A; Coombs RW; Ticona E; Frenkel LM
    AIDS; 2018 Jul; 32(11):1389-1401. PubMed ID: 29683841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Initiating Antiretroviral Treatment Early in Infancy Has Long-term Benefits on the Human Immunodeficiency Virus Reservoir in Late Childhood and Adolescence.
    Avettand-Fenoel V; Lechenadec J; Diallo MS; Fillion M; Melard A; Samri A; Dollfus C; Blanche S; Faye A; Amokrane K; Autran B; Buseyne F; Warszawski J; Frange P;
    Clin Infect Dis; 2021 Dec; 73(11):e4214-e4222. PubMed ID: 34355738
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Absence of detectable HIV-1 viremia after treatment cessation in an infant.
    Persaud D; Gay H; Ziemniak C; Chen YH; Piatak M; Chun TW; Strain M; Richman D; Luzuriaga K
    N Engl J Med; 2013 Nov; 369(19):1828-35. PubMed ID: 24152233
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The sooner, the better: more evidence that early antiretroviral therapy lowers viral reservoirs in HIV-infected infants.
    Li JZ; Gandhi RT
    J Infect Dis; 2014 Nov; 210(10):1519-22. PubMed ID: 24850791
    [No Abstract]   [Full Text] [Related]  

  • 57. Quantifying the turnover of transcriptional subclasses of HIV-1-infected cells.
    Althaus CL; Joos B; Perelson AS; Günthard HF
    PLoS Comput Biol; 2014 Oct; 10(10):e1003871. PubMed ID: 25340797
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of the time to achieve viral control on the dynamics of circulating HIV-1 reservoir in vertically infected children with long-term sustained virological suppression: A longitudinal study.
    Moragas M; Distefano M; Mecikovsky D; Arazi Caillaud S; Cernadas C; Bologna R; Aulicino P; Mangano A
    PLoS One; 2018; 13(10):e0205579. PubMed ID: 30352067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads.
    Lamers SL; Rose R; Maidji E; Agsalda-Garcia M; Nolan DJ; Fogel GB; Salemi M; Garcia DL; Bracci P; Yong W; Commins D; Said J; Khanlou N; Hinkin CH; Sueiras MV; Mathisen G; Donovan S; Shiramizu B; Stoddart CA; McGrath MS; Singer EJ
    J Virol; 2016 Oct; 90(20):8968-83. PubMed ID: 27466426
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART.
    Wiegand A; Spindler J; Hong FF; Shao W; Cyktor JC; Cillo AR; Halvas EK; Coffin JM; Mellors JW; Kearney MF
    Proc Natl Acad Sci U S A; 2017 May; 114(18):E3659-E3668. PubMed ID: 28416661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.